(Q24682133)

full work available at URL

title

Antidepressants and suicide: risk-benefit conundrums (English)

0 references

0 references

0 references

David Healy

0 references

author name string

Chris Whitaker

series ordinal

0 references

language of work or name

English

0 references

publication date

September 2003

0 references

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14517576/pdf/?tool=EBI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517576

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/14517576/?tool=EBI

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517576

https://europepmc.org/articles/PMC193979

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517576

https://europepmc.org/articles/PMC193979?pdf=render

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517576

Journal of Psychiatry & Neuroscience

15 March 2024

published in

0 references

volume

0 references

issue

0 references

page(s)

331-7

0 references

cites work

The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Ten year follow-up of depression after diagnosis in general practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Antidepressant drugs and the emergence of suicidal tendencies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Antidepressants and suicide

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Emergence of intense suicidal preoccupation during fluoxetine treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Suicide Mortality among Patients Treated for Depression in an Insured Population

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Fluoxetine and suicidal preoccupation.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Functional effects of agents differentially selective to noradrenergic or serotonergic systems

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Modelling suicide risk in affective disorders

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

Suicide Rates in the Lundby Study: Mental Illness as a Risk Factor for Suicide

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=193979

The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders

28 November 2018

1 reference

12 December 2020

A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

1 reference

12 December 2020

Suicidality and fluoxetine: is there a relationship?

1 reference

12 December 2020

Postmarketing surveillance by patient self-monitoring: trazodone versus fluoxetine

1 reference

12 December 2020

A double blind comparison of zimelidine and amitriptyline in endogenous depression

1 reference

12 December 2020

Suicide risk in placebo-controlled studies of major depression

1 reference

12 December 2020

Antidepressant Induced Suicidal Ideation: Creaney W, Murray I, Healy D Academic Sub-Department of Psychological Medicine, North Wales Hospital, Denbigh, Clwyd, LL16 5SS

1 reference

12 December 2020

Fluoxetine, Akathisia, and Suicidality: Is There a Causal Connection?

1 reference

12 December 2020

Suicidal ideation related to fluoxetine treatment

1 reference

12 December 2020

[Treatment of depressive states with special consideration of tofranil, a new antidepressant.]

1 reference

12 December 2020

Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992

1 reference

12 December 2020

Deliberate self-harm and antidepressant drugs. Investigation of a possible link

1 reference

12 December 2020

Identifiers

PMC publication ID

193979

0 references